Literature DB >> 20428299

Treatment of depression: antidepressant monotherapy and combination therapy.

Elisa F Cascade1, Amir H Kalali, Pierre Blier.   

Abstract

We investigated the use of antidepressants in the treatment of depression. According to our data, antidepressants are most commonly used alone (85%); however, the prevalence of antidepressant monotherapy decreases as the physician's impression of patient severity increases (92% mild, 84% moderate, 73% severe). Psychiatrists are more likely to use antidepressant combinations than primary care physicians (32% vs. 8%). With respect to combination therapy, the most likely agent to be used in combination with an antidepressant in the treatment of depression was another antidepressant (6.4%); followed by anxiety agents (5.2%), antipsychotics (2.4%), and mood stabilizers and sleep aids (1.2% each). An expert commentary on the data is provided.

Entities:  

Keywords:  antidepressants; augmentation; combination therapy; depression; monotherapy

Year:  2007        PMID: 20428299      PMCID: PMC2860514     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  4 in total

1.  Mood disorders and medical illness: a major public health problem.

Authors:  Dwight L Evans; Dennis S Charney
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

4.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

  4 in total
  4 in total

1.  Treatment of depression: an update on antidepressant monotherapy and combination therapy.

Authors:  Susan Lenderts; Amir Kalali
Journal:  Psychiatry (Edgmont)       Date:  2009-08

2.  Use of antidepressants: expansion beyond depression and anxiety.

Authors:  Elisa F Cascade; Amir H Kalali; Michael E Thase
Journal:  Psychiatry (Edgmont)       Date:  2007-12

3.  Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.

Authors:  Jan Wolff; Pamela Reißner; Gudrun Hefner; Claus Normann; Klaus Kaier; Harald Binder; Christoph Hiemke; Sermin Toto; Katharina Domschke; Michael Marschollek; Ansgar Klimke
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

4.  Multi-modality: a new approach for the treatment of major depressive disorder.

Authors:  Elliott Richelson
Journal:  Int J Neuropsychopharmacol       Date:  2013-01-30       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.